Subrata Patra, Managing Partner at IdeaCapital, noted that with the Government of India's ~$12 billion RDI (Research, Development and Innovation) scheme aimed at mobilizing multi-year financing for the private sector to boost the deep-tech ecosystem, a structural shift towards the sunrise sectors and foundational technologies has come to the fore. As Global Capability Centers expand their footprint, the investment thesis for India is fundamentally changing. The prevailing sentiment at the gathering was that "arbitrage-based" models are no longer sufficient; instead, we are entering an "IP-led" regime where value is measured by application specific innovation differentiation, favoring true technical moats. Investors are moving away from traditional "copycat" models to prioritize specialized, high-impact applications in medical devices, nutrition, and elder care.
As the industry moves toward original innovation, the focus is also sharpening on how these products are marketed and trusted by the consumer. While India has long dominated the global generics market, Jay Kaushik, Managing Partner at Mirra Ventures is now emphasizing the "brand layer." The Indian pharmaceutical industry remains highly fragmented—the current market leader holds only a 6.7% share — leaving a massive vacuum for consolidated, high-trust brands. Investors are pivoting toward a "Value-Added" priority, seeking companies that move beyond simple pills to offer "therapeutically efficacious nutrition" and medical technology. This shift is accompanied by a more cautious, "boots-on-the-ground" approach; as the market matures, the focus is shifting to local players who can navigate India’s unique regulatory "heterogeneity" and deliver consistent returns in a landscape where the typical ROI cycle is often slower than in Western market. Beyond the pharmaceutical branding, this demand for specialized "value-added" care is transforming the physical points of service.
The gathering highlighted several sectors delivering tangible outcomes, a primary requirement for 2026 investors. Ankur Khaitan, Principal at Fireside Ventures highlighted "Indian healthcare is shifting from hospital centric to condition centric and capital will follow platforms owning a condition and delivering measurable outcomes”.
In areas like dental, fertility, and pediatrics, the Indian consumer is demanding a "Do It For Me" (DIFM) model — a programmatic approach to health rather than a DIY one.
However, scaling these specialized clinics and high-tech solutions requires more than just technology; it requires a workforce that currently does not exist in sufficient numbers. As India’s population ages, the value of "human-centric" infrastructure has hit a premium. Dr. Sanjay Arora, Partner from Shubhan Ventures noted that India’s elderly population will reach close to 340 million over the next 20 years, yet a massive "skilling gap" remains. With only 20,000 trained geriatric caregivers against a demand for millions, the transition to a silver economy is not without friction. Investors raised concerns regarding the "execution bottleneck," with Jude Pereira, Managing Director at Nanjgel Group, pointing out that local management talent is now as crucial as the technology itself to scale services. To navigate these issues, the consensus was that hardware (IoT and medical devices) must be wrapped in a "service layer" to be effective. Success in 2026 requires moving from "standalone gadgets" to integrated recovery systems that can operate in the diverse, often infrastructure-light environments of Tier 2 and Tier 3 cities.
The ultimate goal for investing in India in 2026 is to move from "broad optimism" to "precise execution." Investors are no longer looking for "India plays" in name only; they are looking for domain experts who can customize Western ROI models to fit local realities. The future belongs to those who treat India as a "testbed for the world," integrating high-end engineering with local service delivery to solve age-old problems in the "real economy" of health, nutrition, and sustainability.
